Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases
Coya Therapeutics has raised $11.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Coya Therapeutics's investors include Dr. Reddy’s Laboratories, Alzheimer's Drug Discovery Foundation, Greenlight Capital, Allele Capital Partners, Wilbur Ross.
Coya Therapeutics is headquartered in Houston, United States.
Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases
Coya Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Coya Therapeutics — Funding & Investors." VCBacked, January 30, 2026, https://www.vcbacked.co/company/coya-therapeutics. Accessed August 15, 2026.
VCBacked. (2026). Coya Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/coya-therapeutics
{{cite web |title=Coya Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/coya-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated